Capsule

Healthtech / digital pharmacyUSA
New to Unitard
βœ‚οΈ Markdown
PeakΒ $1.15 BillionToday
~-50%
from peak
  1. πŸ¦„
    Became a unicorn
    Apr 2021
  2. πŸ“ˆ
    Peak valuation
    $1.15 Billion ’21
  3. πŸ’”
    Became a Unitard
    Feb 2023
  4. πŸ’Έ
    Last valuation
    ~$575M
Current status
Down round to roughly half its $1.2B peak (early 2023); still private

The rise & fall

5 moments Β· 2015–2023

The key moments, with employee sentiment along the way.

2015
Founded in New York
Eric Kinariwala's fix for the drugstore line: a digital pharmacy that delivers prescriptions to your door.
TechCrunch
Apr 2021
The peak: the pandemic Series D$1.15B
A $300M round from Durable Capital, T. Rowe Price, Whale Rock and Baillie Gifford values the delivery pharmacy above $1B as prescriptions go doorstep.
TechCrunch
2022
Growth stalls; ~13% of staff cut
The 2022-23 downturn ends blitz-expansion; profitability becomes the pitch.
The Information
From the inside Β· Glassdoor reviews, 2022–23
Glassdoor reviews from the period tracked the shift from blitz-expansion to belt-tightening: employees described repeated layoff rounds that left remaining staff covering extra workloads, and couriers reported successive cuts to pay and mileage incentives as the company chased profitability.
Feb 2023
The down round: half the peak
A Series E reportedly prices Capsule at roughly half its $1.2B peak β€” a steep down round that takes the horn with it.
The Information

πŸ’¬ entries paraphrase anonymous, unverified reviews posted publicly on Glassdoor β†—; dated facts carry their source.

How it happened

Capsule is a New York-based digital pharmacy that delivers prescriptions to customers' doors. Pandemic-era demand propelled it past a $1B valuation in April 2021 with a $300M Series D from Durable Capital, T. Rowe Price, Whale Rock and Baillie Gifford.

As growth stalled in the 2022-23 downturn, it cut about 13% of staff and raised a Series E in early 2023 at roughly half its $1.2B peak β€” a steep down round.

Source: The Information (Feb 2023): raising ~$500M, ~half its $1.2B peak

Founder

  • Eric Kinariwala
    Founder & CEO
    Still there β€” Founder & CEOLinkedIn β†—

Current roles as self-reported on LinkedIn, retrieved 2026-08-19. See our methodology.

More from the club

Same sector Β· Healthtech / digital pharmacy
πŸ¦„